The Relative Strength (RS) Rating for Veeva Systems Cl A stock entered a higher percentile Wednesday, as it got a lift from 70 to 74.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's unique rating tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the market's biggest winners tend to have an 80 or better RS Rating as they launch their biggest climbs. See if Veeva Systems stock can continue to show renewed price strength and clear that threshold.
Looking For Winning Stocks? Try This Simple Routine
Is Veeva Systems Stock A Buy?
Veeva Systems stock is building a consolidation with a 225.49 buy point. See if it can break out in volume at least 40% above average. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
In terms of top and bottom line numbers, the company has posted two quarters of rising earnings growth. Sales growth has also risen over the same time frame. The company is expected to release its next quarterly numbers on or around Feb. 29.
Veeva Systems stock holds the No. 1 rank among its peers in the Computer Software-Medical industry group.
